This bill amends the New Mexico Controlled Substances Act to align the scheduling of crystalline polymorph psilocybin with federal law. Specifically, it introduces a new provision stating that upon the rescheduling of crystalline polymorph psilocybin by the United States Food and Drug Administration (FDA), it will be automatically scheduled and listed in accordance with federal regulations. This insertion aims to ensure that state law remains consistent with federal law regarding the control of this substance.

Additionally, the bill modifies the existing Schedule I controlled substances list to include a provision that psilocybin will be scheduled immediately upon its rescheduling by the FDA. This change reflects a proactive approach to drug regulation, allowing for a seamless transition in the legal status of psilocybin as federal guidelines evolve. The bill also clarifies that the authority to control substances does not extend to certain categories such as distilled spirits and tobacco, maintaining existing exemptions within the law.

Statutes affected:
introduced version: 30-31-3, 30-31-6